Table 2 Univariate and mutivariate analysis showing the relationship between concentric hypertrophy and clinical parameters
Univariate model | Multivariate model | |||||
---|---|---|---|---|---|---|
Variables | OR | 95% Cl | P | OR | 95% Cl | P |
Age-10 | 1.61 | 1.12–2.32 | 0.01 | 1.51 | 1.00–2.27 | 0.04 |
Gender | 1.05 | 0.54–2.07 | 0.87 | |||
24SBP-10 | 1.04 | 1.02–1.06 | 0.0001 | NS | ||
24DBP-10 | 1.04 | 1.02–1.07 | 0.002 | NS | ||
Daytime SBP-10 | 1.35 | 1.12–1.64 | 0.002 | NS | ||
Daytime DBP-10 | 1.38 | 1.06–1.79 | 0.02 | NS | ||
Nighttime SBP-10 | 1.64 | 1.30–2.06 | 0.0001 | 1.69 | 1.32–2.17 | 0.0001 |
Nighttime DBP-10 | 1.69 | 1.24–2.28 | 0.001 | NS | ||
MS | 1.58 | 0.78–3.24 | 0.21 | |||
OSA>15 | 2.71 | 1.37–5.37 | 0.004 | 2.73 | 1.26–5.93 | 0.01 |
Aldosterone 24-h urine excretion (μg per 24 h) | 1.01 | 0.98–1.05 | 0.44 | |||
HR-24 h | 1.02 | 0.99 | 1.06 | |||
24-h urinary sodium excretion | 0.99 | 0.99–1.00 | 0.48 |